CNMD vs HAE Stock Comparison

HAE currently leads CNMD in this stock comparison, with AIQ scores of 77 vs 71. The clearest difference is momentum, while CNMD has the stronger value profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 6 points
CNMD
Healthcare
vs
HAE
Healthcare
CNMD
CONMED Corporation
Price
$48.01
Day move
-0.79%
AIQ Score
71/100
Best edge
Value
Sector
Healthcare
HAE
Haemonetics Corporation
Leads
Price
$123
Day move
+1.6%
AIQ Score
77/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between CNMD and HAE?

HAE leads the current stock comparison as Haemonetics Corporation, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

CONMED Corporation vs Haemonetics Corporation

Data as of Nov 18, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

HAE leads

HAE leads by 6 AIQ points, primarily on Momentum and Quality.

Competitive: 5 of 6 evidence groups support HAE, and its current signal state is conflicted.

Evidence agreement: 5 of 6Comparison trend: Stable
CNMD

CONMED Corporation

AIQ Score
71/100
AIQ Edge Score
9/10
HAE

Haemonetics Corporation

Leads
AIQ Score
77/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors HAE over CNMD, 77 versus 71 as of Nov 18, 2026. HAE's advantage is driven primarily by stronger momentum and quality, while CNMD holds the stronger value profile. HAE also shows the stronger technical structure relative to its 50-day moving average. 5 of 6 covered evidence groups favor HAE today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. HAE lead: Stable — the AIQ differential has held near 6 points over 30 sessions.

Compare CONMED Corporation and Haemonetics Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

CNMD
-65.1%
HAE
+122.9%

Total return comparison

Growth of $10,000, distributions reinvested

CNMD $3,490 · HAE $22,290

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare CNMD and HAE against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CNMD advantage
0
HAE advantage
  • Value84 vs 60
    CNMD +24
  • Momentum74 vs 91
    HAE +17
  • Quality66 vs 77
    HAE +11
  • Risk Resilience58 vs 67
    HAE +9

5 of 6 evidence groups favor HAE. HAE’s edge is concentrated in momentum and quality; CNMD keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

CNMD-1 AIQ

Largest factor move: Momentum -2

No signal started or stopped since the prior session; its 7 active signals are unchanged.

HAE0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.64x)

HAE's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — CNMD and HAE both carry a full feed there.

The central trade-off

HAE (Haemonetics Corporation): the stronger current systematic profile, led by momentum and quality.

CNMD (CONMED Corporation): the counter-case, on value, valuation — but at materially higher volatility, 62.2% against 33.1%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

HAE

HAE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

HAE

HAE on combined revenue and EPS growth.

Value

CNMD

CNMD on the peer-relative Value factor, by 24 points.

Momentum

HAE

HAE on the Momentum factor, by 17 points.

Lower downside

HAE

HAE on Risk Resilience, by 9 points.

Analyst upside

HAE

HAE on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureCNMDHAENote
Implied upside to target+4.1%+14.1%HAE has more room
Target dispersion0%+32.8%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering712Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

5 of 6 covered evidence groups favor HAE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreHAE71 vs 77
FundamentalsHAErevenue growth -2.3% vs 5.4%; EPS growth -14.3% vs 39.7%; TTM ROE 1.9% vs 5.2%; gross margin 57.2% vs 58.8%; operating margin 12.1% vs 18.3%
ValuationCNMDValue 84 vs 60
TechnicalsHAEPrice vs 50-day 1.8% vs 8.4%; vs 200-day 20.7% vs 51.3%
Risk ResilienceHAERisk Resilience 58 vs 67
Analyst expectationsHAETarget upside 4.1% vs 14.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CNMD and HAE and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 6 points.
  • 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HAE.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

HAE lead: Stable — the AIQ differential has held near 6 points over 30 sessions.

Jun 1CNMD leads above the line · HAE leads belowNov 18
Today
HAE +6
71 vs 77
7 sessions ago
HAE +5
73 vs 78
30 sessions ago
HAE +7
71 vs 78
90 sessions ago
HAE +8
69 vs 77

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CNMDConflicted

4 bullish / 1 bearish / 2 neutral, conflicted

Only CNMD

  • TRIX Bullish Signal — bullish, momentum, short horizon
HAEConflicted

3 bullish / 1 bearish / 2 neutral, conflicted

No signal that the other name lacks.

Both carry 6 more signals that do not separate them: Golden Cross Active, ADX Trend Strengthening, ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, Uptrend Structure Active.

HAE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CNMDConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.79%, AIQ -1 points).

HAENo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.6%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CNMD closes the Momentum gap — currently 17 points behind, the largest single contributor to HAE's edge.
  2. 2CNMD's Low Volume Rally Warning resolves — a bearish volume rule currently active against it.
  3. 3HAE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

HAE leads on balance
MetricCNMDHAE
Revenue growth (YoY)-2.3%5.4%
EPS growth (YoY)-14.3%39.7%
Gross margin57.2%58.8%
Operating margin12.1%18.3%
Return on equity (TTM)1.9%5.2%
Debt to equity0.771.25

Performance

HAE leads 5 of 6 windows
MetricCNMDHAE
1 week (5 sessions)-1.8%2.5%
1 month (20 sessions)8.3%3.9%
3 months (63 sessions)2.7%36.2%
6 months (126 sessions)42.5%118.4%
Year to date24.6%53.4%
1 year (252 sessions)16.1%68.1%

Technicals

HAE has the stronger structure
MetricCNMDHAE
RSI (14)56.858.7
ADX (14)23.338.6
Price vs 50-day1.8%8.4%
Price vs 200-day20.7%51.3%
Volatility (1M, annualized)62.2%33.1%

Risk

HAE is the more resilient
MetricCNMDHAE
Beta0.790.24
Sharpe ratio0.481.35
Sortino ratio0.762.46
Max drawdown-30.3%-40.1%
Current drawdown-5.7%-3.5%
Annualized volatility47%41%
Value at risk (95%)-4%-3.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CNMD or HAE?

On the Algovestiq AIQ Score, HAE is the stronger of the two as of Nov 18, 2026, scoring 77 against CNMD's 71. The edge comes from momentum and quality. CNMD is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CNMD or HAE the better buy right now?

HAE carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Competitive — 5 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor HAE over CNMD?

The composite weights Quality, Value, Momentum and Risk Resilience. CNMD leads Value by 24 points; HAE leads Momentum by 17 points; HAE leads Quality by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CNMD or HAE?

Analyst price targets imply +4.1% upside for CNMD and +14.1% for HAE, so the Street currently favors HAE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CNMD or HAE?

CNMD is the better-valued of the two on the peer-relative Value factor. CNMD on the peer-relative Value factor, by 24 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CNMD or HAE?

HAE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CNMD or HAE?

HAE on the Momentum factor, by 17 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CNMD or HAE?

HAE is the more resilient of the two, so the other name carries the higher downside risk. HAE on Risk Resilience, by 9 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CNMD more profitable than HAE?

HAE leads on the comparable margin measures — gross margin 57.2% vs 58.8%; operating margin 12.1% vs 18.3%; ttm roe 1.9% vs 5.2%.

Is HAE's lead over CNMD getting stronger or weaker?

HAE lead: Stable — the AIQ differential has held near 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.

What would change the CNMD vs HAE verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CNMD closes the Momentum gap — currently 17 points behind, the largest single contributor to HAE's edge; CNMD's Low Volume Rally Warning resolves — a bearish volume rule currently active against it; HAE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about CNMD and HAE?

CNMD: 4 bullish / 1 bearish / 2 neutral, conflicted. HAE: 3 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CNMD is Golden Cross Active (bullish, long horizon). On HAE it is Golden Cross Active (bullish, long horizon).

Compare CNMD and HAE with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.